Labcorp (LH) director Jeffrey A. Davis awarded 773 Restricted Stock Units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Jeffrey A. Davis received an equity grant of 773 Restricted Stock Units on February 10, 2026. Each unit represents the right to receive one share of Labcorp common stock. The Restricted Stock Units vest fully on February 10, 2027.

After this award, Davis beneficially owns a total of 1,670 Restricted Stock Units in Labcorp through direct ownership, reflecting his aggregate RSU holdings as reported.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Davis Jeffrey A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	773	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 1,670 shares (Direct)

Footnotes (1)

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. The Restricted Stock Units vest fully on February 10, 2027. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/12/2026 - 11:02 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis Jeffrey A.

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

27215

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	02/10/2026		A		773		⁽²⁾	⁽²⁾	Common Stock	773	$0	1,670⁽³⁾	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Jeffrey A. Davis	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What equity award did Labcorp (LH) director Jeffrey A. Davis receive?

Jeffrey A. Davis received a grant of 773 Restricted Stock Units from Labcorp. Each unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock, providing stock-based compensation linked directly to the company’s equity.

When do Jeffrey A. Davis’s 773 Labcorp (LH) Restricted Stock Units vest?

The 773 Restricted Stock Units granted to Jeffrey A. Davis vest fully on February 10, 2027. Vesting means he becomes entitled to receive Labcorp common shares underlying the units as of that date, assuming applicable service or other conditions are satisfied.

How many Restricted Stock Units does Jeffrey A. Davis own after this Labcorp (LH) transaction?

Following the reported grant, Jeffrey A. Davis beneficially owns 1,670 Restricted Stock Units. This figure represents the aggregate number of Labcorp Restricted Stock Units held by him after the award reported in this Form 4 insider transaction.

Is the February 10, 2026 Labcorp (LH) Form 4 transaction a purchase or a grant?

The February 10, 2026 transaction is a grant or award, not an open-market purchase. It is coded as an acquisition of 773 Restricted Stock Units, representing stock-based compensation awarded to director Jeffrey A. Davis by Labcorp Holdings Inc.

Does Jeffrey A. Davis hold his Labcorp (LH) Restricted Stock Units directly or indirectly?

Jeffrey A. Davis holds his Labcorp Restricted Stock Units directly. The Form 4 lists his ownership form as “D” for direct, indicating the reported 1,670 Restricted Stock Units are directly attributable to him rather than through an intermediary entity.